Middle East and Africa Mobile ECG Devices Market

Market Introduction

ECG devices monitors and record electrical activity of the heart and the device detects and picks up electrical impulses generated by the polarization and depolarization of cardiac tissue and translate them into waveform. A mobile ECG monitoring device is the complete diagnostic solution for diagnosis of arrhythmia and provides full disclosure ECG signal, data, analysis, reporting, and allows monitoring of heart at anyplace at any time, such as, home. It consists of two divisions, including, the analog signal receiver that reads, amplifies and convert the signal to digital form and the other part is a wireless transmitter that sends the data to storage devices so that it can be analyzed by physicians and medical personnel. It connect with Wi-Fi, Bluetooth, or the internet to mobiles, tablets, among others.

Middle East and Africa Mobile ECG Devices Strategic Insights

Strategic insights for the Middle East and Africa Mobile ECG Devices provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Middle East and Africa Mobile ECG Devices Report Scope

Middle East and Africa Mobile ECG Devices Regional Insights

The geographic scope of the Middle East and Africa Mobile ECG Devices refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The Middle East and Africa mobile ECG devices market is expected to reach US$ 93.27 million by 2028 from US$ 74.25 million in 2021; it is estimated to grow at a CAGR of 3.6% from 2021 to 2028. The market growth is attributed to technological advancements in portable and handheld ECG devices, rise in the incidence of cardiovascular diseases, increase in geriatric population, and favorable government regulations regarding monitoring devices. However, aspects such as unfavorable reimbursement policies and market saturation restrict the mobile ECG devices market growth in Middle East and Africa.

The mobile ECG devices market players are focusing their R&D capabilities for developing technologically advanced products. The traditional counterparts of these devices are uncomfortable to use and can be worn for a limited periods. Thus, the current and ongoing development associated with the mobile devices helped the players to enter the consumer market at a significant rate. The adoption for mobile ECG devices is increasing with growing investments in healthcare infrastructure and rise in acceptance for modern technologies. The notable benefits of these devices include convenience, ease of use, and continuous monitoring, which ensure accuracy in results and improved treatment effectiveness. The increasing awareness regarding the need of the early detection and management of CVDs and other heart problems propels the demand for mobile ECG devices. Additionally, with the technological advancements, mobile systems have emerged as a cost-effective strategy for consumer care. The commercially advanced devices enabled with the Bluetooth sensor technology and equipped with mobile apps drive the popularity of mobile ECG devices, which are worn continuously by patients. Such devices send ECG readings to users’ smartphones that are connected to the devices via Bluetooth. In the last 5 years, there has been an enormous surge in the adoption of wearable and handheld ECG devices, and the associated smartphone apps that allow consumers to record 1–6-lead ECG. Clinical studies also highlight the high sensitivity of wireless mobile ECG devices, which helps detect atrial fibrillation and other cardiac abnormalities at any time, through interactions between the device and user, mediated by smartphones that help overcome constraints of place and time. As a result, the healthcare professionals can receive automated updates, which allows them to offer structured CVD management and minimize clinical visits.

The mobile ECG devices market is characterized by the presence of many small and big companies. The market players are adopting strategies such as new product launches and partnerships to increase their market share and gain a competitive edge over other players.  The AliveCor’s Kardia devices allow iPhones and Kardia watch to record an ECG within 30-second, and with the help of AI algorithms, the devices automatically examine the waveforms for various arrhythmias. Medtronic wearable, clinical-grade, stick-on cardiac monitor, offers interfaces with patients' mobile devices to help them mark the heart events and allow data transmission to a clinician's office or automated ECG monitoring system. Thus, advancements in mobile ECG products and other strategies by key market players are leading to significant trends in the mobile ECG devices market.

The COVID-19 pandemic has become the most significant challenge in the Middle East and Africa. Many countries in the region have underdeveloped and underfunded healthcare systems. The sudden emergence of SARS-CoV-2 exerted severe pressure on healthcare facilities in the region. Furthermore, the shortage of hospital supplies is accelerating the criticality of the condition. The shift in focus of healthcare professionals during the early stages of the pandemic on the management of COVID-19 case, substantially hampered the number of other diagnostic procedures and elective surgeries in the region. The spread of SARS-CoV-2 caused heavy burdens on healthcare professionals. Cardiac surgeons were overloaded with emergency cardiac surgeries, COVID patient management, and safety guidelines implementation to prevent the spread of the virus. Therefore, empowering family physicians and their patients with accurate and portable home diagnostic devices, including electrocardiogram (ECG) devices and oximeters became a priority in Asia-Pacific countries. Moreover, the implementation of social distancing policies resulted into limited patients visits to cardiac centers, which drastically lowered the demand and adoption of mobile ECG devices in Middle East and Africa. Apart from this, a huge population already faces a large burden of noncommunicable diseases, making them more vulnerable to the novel coronavirus. However, the launch of COVID-19 vaccination programs in several countries would ultimately improve the situation in the coming years.

Key Market Segments

The Middle East and Africa mobile ECG devices market, based on type, has been segmented into monitoring ECG systems and diagnostic ECG systems. The monitoring ECG systems segment held a larger share of the market in 2021. Moreover, the monitoring ECG systems segment is anticipated to register a higher CAGR in the market during the forecast period due to product innovation, and incumbent usage and high-volume consumption of these products.

The Middle East and Africa mobile ECG devices market, based on application, is segmented into handheld, band, pen, and others. In 2021, the handheld segment held the largest share of the market. Moreover, the segment is also expected register the fastest CAGR in the market during 2021–2028.

The Middle East and Africa mobile ECG devices market, based on end user, is segmented into personal users, hospitals and clinics, and ambulatory services. In 2021, the personal users segment accounted for the largest share of the market. Moreover, the segment is expected to witness the highest CAGR in the market during 2021–2028.

Major Sources and Companies Listed

A few of the primary and secondary sources associated with this report on the Middle East and Africa mobile ECG devices market are the Saudi Health Ministry, World Health Organization (WHO), and Saudi Arabian Monetary Agency (SAMA).

Reasons to buy the report

• Determine prospective investment areas based on a detailed trend analysis of Middle East and Africa mobile ECG devices market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
• Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels driving the Middle East and Africa mobile ECG devices market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Middle East and Africa mobile ECG devices market.

MIDDLE EAST AND AFRICA MOBILE ECG DEVICES MARKET SEGMENTATION

By Type

• Monitoring ECG Systems
• Diagnostics ECG Systems

By Modality

• Handheld
• Band
• Pen
• Others

By End Use

• Personal users
• Hospitals and Clinics
• Ambulatory Services

By Country

• South Africa
• Saudi Arabia
• UAE
• Rest of Middle East and Africa

Company Profiles

• Koninklijke Philips N.V.
• Medtronic
• AliveCor, Inc
• Nihon Kohden Corporation